Seer (RUO, not doing cancer?)
Research-use proteomics that maps and analyzes proteins to help identify biomarkers.
Seer offers proteomics, the mapping and analysis of proteins using mass spectrometry or target capture, with blood or FFPE tissue as input. This kind of analysis can model signature pathways to identify biomarkers. Seer's platform is research use only and may not currently focus on cancer, so patients should treat it as a research resource, not a clinical test.
Vetted listing
Ask anything about Seer
Get started with Seer (RUO, not doing cancer?)
What it costs
Seer hasn't shared insurance details with us yet. Check what your plan covers, or ask Seer when you connect.
Get guidance specific to your case
This page is general information. Add your records and we tailor answers to your diagnosis.
